¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"linear transformation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • linear phased array
    ¼±ÇüÀ§»óÂ÷¹è¿­, ÁÙÀ§»óÂ÷¹è¿­
  • linear regression
    ¼±Çüȸ±Í
  • linear scale
    ±Õµî´«±Ý
  • linear scan
    ¼±½ºÄµ
  • linear scleroderma
    ¼±ÇǺΰæÈ­Áõ
  • linear sequenced array
    ¼±Çü¼øÂ÷¹è¿­, ÁÙ¸ð¾ç¼ø¼­¹è¿­
  • linear shadow
    ¼±À½¿µ
  • linear switched array
    ¼±Çü±³´ë½Ä¹è¿­, ÁÙ±³´ë½Ä¹è¿­
  • linear transducer
    ¼±ÇüŽÃËÀÚ
  • linear type constitution
    ¼±ÇüüÇü
  • verrucous linear nevus
    »ç¸¶±Í¸ð¾ç¼±¸ð¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • linear type constitution
    ¼±ÇüüÇü
  • linear density
    ¼±À½¿µ
  • linear lichenoid dermatosis
    ¼±»óż±¸ð¾çÇǺκ´
  • linear equation
    ÀÏÂ÷¹æÁ¤½Ä
  • linear fracture
    ¼±»ó°ñÀý
  • linear skull fracture
    ¼±»ó¸Ó¸®°ñÀý, µÎ°³°ñ¼±»ó°ñÀý
  • general linear model
    ÀϹݼ±»ó¸ðµ¨
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • linear
    ÁÙ¸ð¾ç-, ¼±Çü-, ¼±»ó-
  • linear molecule
    ¼±ÇüºÐÀÚ
  • linear nevus
    ¼±¸ð¹Ý
  • linear perspective
    ¼±»óÅõ½Ã
  • linear regression
    ¼±Çüȸ±Í
  • linear scale
    ±Õµî´«±Ý
  • linear scan
    ¼±½ºÄµ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • transformation of energy
    ¿¡³ÊÁöº¯È¯ (¡­Ü¨üµ).
  • arrays, linear sequenced
    ¼±Çü ¼øÂ÷ ¹è¿­ (àÊû¡ â÷ó­ ÛÉæê)
  • bullous dermatosis,linear iga
    ¼±»ó IgA (àÊß¾¡­)
  • fine horizontal linear opacity
    ¹Ì¼¼ÇÑ ¼öÆò¸éÇü ¼±»ó ºÒÅõ¸íü
  • general linear model
    ÀϹÝÀû ¼±Çü ¸ðµ¨, ÀÏ¹Ý ¼±»ó ¸ðµ¨
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • inflammatory linear verrucous epidermal nevus (ILVEN)
    ¿°Áõ¼º ¼±»ó »ç¸¶±Í¾ç Ç¥ÇǸð¹Ý
  • linear
    ¼±Çü (àÊû¡)
  • linear
    ¼±Çü, ¼±»ó
  • linear IgA bullous dematosis
    ¼±»ó ¸é¿ª±Û·ÎºÒ¸°A ¼öÆ÷¼ºÇǺκ´
  • linear IgA dermatitis
    ¼±»ó ¸é¿ª±Û·ÎºÒ¸°A ÇǺο°
  • linear IgA dermatosis
    ¼±»ó ¸é¿ª±Û·ÎºÒ¸°A ÇǺκ´(Áõ)
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear accelerator
    ¼±Çü°¡¼Ó±â(¡­Ê¥áÜÐï).
  • linear amputation
    ¼±Çü Àý´Ü(àÊû¡ï·Ó¨), Á÷¼± Àý´Ü(òÁàÊôîÓ¨).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • linear correlation
    ¼±Çü »ó°ü(àÊû¡ßÓμ)
  • linear density gradient
    ¼± ¹Ðµµ(à»ÚËÓø)±â¿ï±â
  • linear dichroism
    ¼±Çü ÀÌ»ö¼º(àÊû¡ì£ßäàõ)
  • linear electric field effect
    ¼±Çü Àü±âÀåÈ¿°ú(àÊû¡ï³Ñ¨íÞüùÍý)
  • linear energy transfer
    ¼±Çü(àÊû¡) ¿¡³ÊÁöÀüÀÌ(ï®ì¹)
  • linear growth
    ¼±Çü¼ºÀå(àÊû¡à÷íþ)
  • linear inhibition
    ¼±ÇüÀúÇØ(àÊû¡îÁúª)
  • linear metabolic pathway
    ¼±Çü ´ë»ç°æ·Î(àÊû¡ÓÛÞóÌèÖØ)
  • linear polymer
    ¼±ÇüÁßÇÕü(àÊû¡ñìùêô÷)
  • linear polyphosphate
    ¼±ÇüÁßÀλê(àÊû¡ñììÝß«)
  • linear regression
    ¼±Çüȸ±Í(àÊû¡üÞÏý)
  • linear velocity
    ¼±¼Óµµ(àÊáÜÓø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • linear scan motion
    ¼±Çü½ºÄµ¿îµ¿
  • linear sequenced array
    ¼±Çü¿¬¼â¹è¿­
  • linear shadow
    ¼±»óÀ½¿µ
  • linear streak
    ¼±»ó¼±
  • linear switched array
    ¼±Çü±³´ë½Ä¹è¿­
  • linear transducer
    ¼±Çü ŽÃËÀÚ
  • linear transducer array
    ¼±»óÆ®·£½ºµà¼­¹è¿­
  • linear ulcer
    ¼±»ó±Ë¾ç
  • peripheral linear enhancement
    ¸»Ãʼ±ÇüÁ¶¿µÁõ°­
  • phased linear array type
    À§»óÂ÷¼±Çü¹è¿­½Ä
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LLETZ large loop excision of the transformation zone
LTT lactose tolerance test; leucine tolerance test; limited treadmill test; lymphocyte transformation te...
NTZ normal transformation zone
PBLT peripheral blood lymphocyte transformation
PNT partial nodular transformation; patient
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LLETZ Large Loop Excision of the Transformation Zone
LETS Large, external, transformation-sensitive
LTT Lymphocyte Transformation Test
LBT Lymphocyte blast transformation
LT Lymphocyte transformation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • linear optical characteristics
    ¼±Çü ±¤ÇРƯ¼º
  • linear polymer
    ¼±»ó ÁßÇÕü
    ºÐÀÚÀÇ Çü»óÀÌ »ç»óÀÎ ÁßÇÕ¹°·Î ºÐÁöÇÑ ÁßÇÕ¹°, ȤÀº °¡°øµÈ ÁßÇÕ¹°¿¡ ´ëºñµÈ´Ù´Â ¶æ.
  • linear shadow
    ¼±»ó À½¿µ
  • linear tomography
    ¼±Çü ´ÜÃþ ÃÔ¿µ¼ú, ¼±Çü ´ÜÃþ ÃÔ¿µ¼ú¹ý
  • peripheral linear enhancement
    ¸»ÃÊ ¼±Çü Á¶¿µ Áõ°­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
linear skull fracture A skull fracture resembling a line.
(05 Mar 2000)
abiotic transformation <biochemistry> An abiotic transformation is any process in which a chemical in the environment is altered by non-biological mechanisms (such as by exposure to sunlight).
(09 Oct 1997)
bacterial transformation <microbiology> A genetics lab procedure where bacteria are induced to accept and incorporate into their genome foreign pieces of cell-less, isolated DNA, often in the form of a plasmid.
The DNA to be introduced usually contains a selectable marker so that the bacteria which successfully incorporate the DNA can be selected for.
(09 Oct 1997)
blast transformation <haematology> The morphological and biochemical changes in lymphocytes, both B and T, on exposure to antigen or to a mitogen. The cells appear to move from G0 to G1 stage of the cell cycle. They usually enlarge and proceed to S phase and mitosis later. The process probably involves receptor cross linking on the plasma membrane.
(18 Nov 1997)
genetic transformation <molecular biology> Genetic change brought about by the introduction of exogenous DNA into a cell.
See: transformation, germ line transformation, transfection.
(18 Nov 1997)
germ line transformation Micro injection of foreign DNA into an early embryo, so that it becomes incorporated into the germ line of the individual and thus stably inherited in subsequent generations of transgenic organisms. Typically, the DNA would be a reporter gene or cDNA in a vector such as a transposon, that might also carry a visible marker gene such as eye or coat colour), so that successful transformation could readily be detected.
(18 Nov 1997)
viral transformation <oncology, virology> Malignant transformation of an animal cell in culture, induced by a virus.
(18 Nov 1997)
cell transformation Morphological and physiological changes resulting from infection of an animal cell by an oncogenic virus.
(05 Mar 2000)
cell transformation, neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
(12 Dec 1998)
cell transformation, viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus.
(12 Dec 1998)
Haldane transformation The multiplication of inspired oxygen concentration by the ratio of expired to inspired nitrogen concentrations in the calculation of oxygen consumption or respiratory quotient by the open circuit method.
(05 Mar 2000)
sol gel transformation Transition between more fluid cytoplasm (endoplasm) and stiffer gel like ectoplasm proposed as a mechanism for amoeboid locomotion: since the endoplasm cannot really be considered a simple fluid and has visco elastic properties like a gel, the term is misleading.
(18 Nov 1997)
spontaneous transformation Transformation of a cultured cell that occurs without the deliberate addition of a transforming agent. Cells from some species, especially rodents, are particularly prone to such spontaneous transformation.
(18 Nov 1997)
nodular transformation of the liver A rare condition in which nodules of hyperplastic hepatocytes develop without fibrosis or general loss of lobular architecture.
Synonym: nodular regenerative hyperplasia.
(05 Mar 2000)
transformation <chemistry> The change of form or structure, conversion from one form to another.
<oncology> The change that a normal cell undergoes as it becomes malignant. In eukaryotes, the conversion of normal cells to malignant cells in cell culture.
Origin: L. Formatio = formation
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á